Ocular Therapeutix (OCUL) Amortizatization of Intangibles (2015 - 2019)
Ocular Therapeutix (OCUL) recorded quarterly Amortizatization of Intangibles of $143000.0 in Q2 2019, down 23.53% quarter-over-quarter from $187000.0 in Q1 2019.
Ocular Therapeutix (OCUL) Amortizatization of Intangibles (2015 - 2019) Analysis & Trends
Ocular Therapeutix's Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at $143000.0 for Q2 2019.
- In Q2 2019, Amortizatization of Intangibles changed N/A year-over-year to $143000.0; the TTM figure through Jun 2019 stood at $330000.0 (changed N/A YoY), while the FY2017 annual figure was $17000.0, down 90.86% from the prior year.
- Amortizatization of Intangibles was $143000.0 for Q2 2019 at Ocular Therapeutix, down from $187000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $470000.0 in Q4 2015 to a low of -$148000.0 in Q3 2015.
- Historically, Amortizatization of Intangibles has averaged $68000.0 across 4 years, with a median of $16500.0 in 2016.
- Biggest YoY gain for Amortizatization of Intangibles was 677.78% in 2016; the steepest drop was 97.23% in 2016.
- A 4-year view of Amortizatization of Intangibles shows it stood at $470000.0 in 2015, then slumped by 97.23% to $13000.0 in 2016, then plunged by 53.85% to $6000.0 in 2017, then soared by 2283.33% to $143000.0 in 2019.
- The last three Amortizatization of Intangibles figures came in at $143000.0 (Q2 2019), $187000.0 (Q1 2019), and $6000.0 (Q2 2017), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Ocular Therapeutix | 2.01 Bn | 2.01 Bn | 9.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 143,000.00 |
| Jun 30, 2019 | 143,000.00 |
| Mar 31, 2019 | 187,000.00 |
| Mar 31, 2019 | 187,000.00 |
| Jun 30, 2017 | 6,000.00 |
| Jun 30, 2017 | 6,000.00 |
| Mar 31, 2017 | 11,000.00 |
| Mar 31, 2017 | 11,000.00 |
| Dec 31, 2016 | 13,000.00 |
| Dec 31, 2016 | 13,000.00 |
| Sep 30, 2016 | 20,000.00 |
| Sep 30, 2016 | 20,000.00 |
| Jun 30, 2016 | 49,000.00 |
| Jun 30, 2016 | 49,000.00 |
| Mar 31, 2016 | 104,000.00 |
| Mar 31, 2016 | 104,000.00 |
| Dec 31, 2015 | 470,000.00 |
| Dec 31, 2015 | 470,000.00 |
| Sep 30, 2015 | -148,000.00 |
| Sep 30, 2015 | -148,000.00 |